Rituximab + Chemo Ups Survival in Pediatric B-Cell Non-Hodgkin Lymphoma

THURSDAY, June 4, 2020 -- For children and adolescents with high-grade, high-risk, mature B-cell non-Hodgkin lymphoma, rituximab added to standard lymphomes malins B (LMB) chemotherapy prolongs event-free survival, according to a study published in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news